Net revenue for the first quarter of fiscal 2025 was $257.7 million. GAAP net loss for the first quarter of fiscal 2025 was $23.1 million, or a loss of $0.58 per basic share. Non-GAAP net income for ...
STOUGHTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback